Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin effect on atherosclerotic plaque metabolism assessed by 18F-NaF PET-CT
2018-003837-13Phase 4Completed
- Sponsor
- Centro Hospitalar e Universitário de Coimbra
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rosuvastatin in atherosclerosis, sponsored by Centro Hospitalar e Universitário de Coimbra. Started Nov 2019; status: completed.
02
Drugs
rosuvastatin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on 2018-003837-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003837-13.